| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 05/16/2013 | WO2013070657A1 Modulators of the g protein-coupled mas receptor and the treatment of disorders related thereto |
| 05/16/2013 | WO2013070236A1 Methods and compositions for treating hemorrhoids while providing local anesthetic and anti-inflammatory effects |
| 05/16/2013 | WO2013070048A1 Composition for preventing or treating ischaemic heart disease comprising, as an active ingredient, age-albumin synthesis or secretion inhibitor for mononuclear phagocyte system cells |
| 05/16/2013 | WO2013069661A1 Vascular progenitor cell sheet derived from induced pluripotent stem cells, and production method therefor |
| 05/16/2013 | WO2013068875A1 2-thiopyrimidinones |
| 05/16/2013 | WO2013068600A1 Medicament for the treatment of cardiac disease |
| 05/16/2013 | WO2013068504A1 Apotransferrin for the treatment of brain stroke |
| 05/16/2013 | WO2013068306A1 [1, 2, 3] triazolo [4, 5 -d] pyrimidine derivatives as agonists of the cannabinoid receptor 2 |
| 05/16/2013 | WO2013067579A1 Adiposity-modulating molecules and uses therefor |
| 05/16/2013 | WO2012177847A3 Methods of dissolving blood clots and the like |
| 05/16/2013 | WO2012167261A3 Compositions and methods for treating and preventing neointimal stenosis |
| 05/16/2013 | WO2012047966A8 Compositions and methods for treating ocular edema, neovascularization and related diseases |
| 05/16/2013 | US20130123170 Growth Hormone Releasing Peptides |
| 05/16/2013 | US20130122076 Transdermal Patch Having Ultrasound Transducer for Administering Thrombolytic Reagents to Patients Having a Protein Misfolding Disease |
| 05/16/2013 | US20130122018 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
| 05/16/2013 | US20130121974 Methods of making enhanced, autologous fat grafts |
| 05/16/2013 | CA2854949A1 Apotransferrin for the treatment of brain stroke |
| 05/16/2013 | CA2853833A1 Modulators of the g protein-coupled mas receptor and the treatment of disorders related thereto |
| 05/16/2013 | CA2853784A1 Treatment of blood lipid abnormalities and other conditions |
| 05/16/2013 | CA2853024A1 2-thiopyrimidinones |
| 05/16/2013 | CA2850458A1 [1, 2, 3] triazolo [4, 5 -d] pyrimidine derivatives as agonists of the cannabinoid receptor 2 |
| 05/16/2013 | CA2840900A1 Composition for prevention or treatment of ischemic cardiac disease,comprising inhibitor against age-albumin synthesis or release of mononuclearphagocyte system cells as active ingredient |
| 05/15/2013 | EP2592145A1 Medicament for the treatment of cardiac disease |
| 05/15/2013 | EP2592080A1 Crystal of fused pyridine compound salt |
| 05/15/2013 | EP2592076A1 Substituted pyridine compound |
| 05/15/2013 | EP2592071A1 Tricyclic heterocyclic compounds |
| 05/15/2013 | EP2591789A2 Adherent cells from adipose or placenta tissues and use thereof in therapy |
| 05/15/2013 | EP2591785A1 Use of 5 -androstane (alkyl)-3 ,5,6 -triol in preparing neuroprotective drugs |
| 05/15/2013 | EP2591784A1 Pyridine-2-one-derivatives as modulators of stress-activated protein kinase system |
| 05/15/2013 | EP2591783A1 Combination anticoagulant therapy with a compound that acts as a factor Xa inhibitor |
| 05/15/2013 | EP2591093A2 Endothelial cell production by programming |
| 05/15/2013 | EP2590987A1 Ring-fused 4 -aminopyrimidines and use thereof as stimulators of soluable guanylate cyclases |
| 05/15/2013 | EP2590979A1 Ring-fused pyrimidines and triazines and use thereof for the treatment and/or prophylaxis of cardiovascular diseases |
| 05/15/2013 | EP2590956A1 5-(biphenyl-4-yl)-3-phenyl-1,2,4-oxadiazolyl derivatives as ligands on the sphingosine 1-phosphate (s1p) receptors |
| 05/15/2013 | EP2590950A1 N-cyclyl-3 - (cyclylcarbonylaminomethyl) benzamide derivatives as rho kinase inhibitors |
| 05/15/2013 | EP2590942A1 Rho kinase inhibitors |
| 05/15/2013 | EP2590937A1 Phenoxypropanol derivatives and their use in treating cardiac and cardiovascular diseases |
| 05/15/2013 | EP2590664A1 Methods for the prevention or treatment of no-reflow following ischemia/reperfusion injury |
| 05/15/2013 | EP2590658A2 Compositions and methods for removal or destruction of amyloid fibril or amyloid adhesin comprising aggregates |
| 05/15/2013 | EP2590652A1 Pharmaceutical compositions containing vanoxerine |
| 05/15/2013 | EP2590642A2 Pkc activators and anticoagulant in regimen for treating stroke |
| 05/15/2013 | EP2590624A1 Use of glabranin for stimulating hair growth |
| 05/15/2013 | EP2590623A1 Malvidin for promoting hair growth |
| 05/15/2013 | CN103108882A Polycrystalline type object of CDDO BIEA and use thereof |
| 05/15/2013 | CN103108637A Methods of intravenous administration of glyburide and other drugs |
| 05/15/2013 | CN103103244A Walnut blood pressure-lowering active peptide, its preparation method and application |
| 05/15/2013 | CN103103092A Silkworm male moth mulberry wine as well as preparation method thereof |
| 05/15/2013 | CN103103090A Silkworm chrysalis cordyceps wine and preparation method thereof |
| 05/15/2013 | CN103103089A Silkworm chrysalis cordyceps bombyx wine and manufacturing method thereof |
| 05/15/2013 | CN103103075A Chinese herbal medicine health care wine capable of smoothly reducing blood pressure |
| 05/15/2013 | CN103103074A Healthful wine |
| 05/15/2013 | CN103102376A Separation method for simultaneously separating cowherb seed flavonoid glycoside and cowherb seed total saponin |
| 05/15/2013 | CN103102349A Protein kinase inhibitor and composition and application thereof |
| 05/15/2013 | CN103102345A Aminoquinazoline derivative, salts thereof and application method |
| 05/15/2013 | CN103102344A Aminoquinazoline derivative, salts thereof and application method |
| 05/15/2013 | CN103102342A Aminoquinazoline derivative, salts thereof and application method |
| 05/15/2013 | CN103102303A Benzylamine derivatives as CETP inhibitors |
| 05/15/2013 | CN103100089A Oral pH responsive intestinal targeting vector as well as preparation method and applications thereof |
| 05/15/2013 | CN103100078A Traditional Chinese medicine preparation for treating cardiac arrhythmia |
| 05/15/2013 | CN103100050A Chinese medicament for treating angina |
| 05/15/2013 | CN103100029A Wu houshan bitter tea |
| 05/15/2013 | CN103100027A Traditional Chinese medicine for treating coronary heart disease |
| 05/15/2013 | CN103099996A Traditional Chinese medicine composition for treating varicose vein of lower limbs |
| 05/15/2013 | CN103099973A Medicinal liquor for preventing treating hypertension |
| 05/15/2013 | CN103099971A Chinese medicinal composition for treating vascular vertigo |
| 05/15/2013 | CN103099926A Externally used traditional Chinese medicine (TCM) preparation for treating vertebral artery type cervical spondylopathy |
| 05/15/2013 | CN103099924A Chinese herbal medicine for treating palpitation caused by deficiency of qi and blood and yang deficiency of spleen and kidney |
| 05/15/2013 | CN103099916A Three-flower hemorrhoid-dispersing pills for treating hemorrhoid diseases |
| 05/15/2013 | CN103099897A Formula Chinese herbal medicament capable of radically curing hypertension |
| 05/15/2013 | CN103099896A Herb tea for treating cardiovascular and cerebrovascular diseases |
| 05/15/2013 | CN103099854A Application of Shenkang injection in preparing drug for preventing and treating cardiovascular and cerebrovascular diseases |
| 05/15/2013 | CN103099847A Formula of traditional Chinese medicine for treating neurasthenia |
| 05/15/2013 | CN103099845A Method for extracting perillaseed hydrophilic chemical component from perillaseed oil residue |
| 05/15/2013 | CN103099834A Preparation for treating coronary heart disease and preparation method of preparation |
| 05/15/2013 | CN103099832A Method for biotransformation of pseudo-ginseng by using Candida |
| 05/15/2013 | CN103099827A Extraction preparation method for flavones from grass leaves with blood enriching |
| 05/15/2013 | CN103099826A Method for extracting taxusflavone from taxus chinensis leaves |
| 05/15/2013 | CN103099803A Method for solubilization and synchronous dissolution of bilobalide |
| 05/15/2013 | CN103099802A Application of salvianolic acid A composition in preparation of medicine for salvaging ischemic penumbra |
| 05/15/2013 | CN103099801A Application of 13-methyitetradecanoic acid in preparation of medicine for treating focal cerebral ischemia |
| 05/15/2013 | CN103099798A Preparation method of soybean isoflavone-chitosan slow-release microcapsules |
| 05/15/2013 | CN103099788A Traditional Chinese medicine composite decoration from powder, preparation and decoction methods and dosage relation thereof |
| 05/15/2013 | CN103099780A Preparation method of hydrogen-microbubble-containing aqueous solution, and product and application of method |
| 05/15/2013 | CN103099493A Medicine pillow used for prevention and treatment of hypertension |
| 05/15/2013 | CN102488741B Preparation method of pueraria root flavone extract and its product |
| 05/15/2013 | CN102366412B Preparation method of tolvaptan tablet |
| 05/15/2013 | CN102309727B Chinese patent medicine for facial beautification and longevity |
| 05/15/2013 | CN102309625B Traditional Chinese medicinal composition for treating hemorrhoidal diseases and preparation method for soup thereof |
| 05/15/2013 | CN102309475B Levocarnitine for injection and preparation method thereof |
| 05/15/2013 | CN102295604B Preparation method of telmisartan intermediate |
| 05/15/2013 | CN102283828B Application of tetrahydroxybenzopyrone compound |
| 05/15/2013 | CN102283823B Application of tetrahydroxy propenone compounds |
| 05/15/2013 | CN102274319B Preparation method of rhomotoxine hydrolysis product |
| 05/15/2013 | CN102219741B Process for preparing benzazepine compounds or salts thereof |
| 05/15/2013 | CN102076671B Triazole derivative or salt thereof |
| 05/15/2013 | CN102060921B High-stability VPAC2 type receptor specific activator MHDBAY, preparation method and application thereof |
| 05/15/2013 | CN101991589B Glycerol fructose injection and preparation method thereof |
| 05/15/2013 | CN101946003B Anti-adam-15 antibodies and utilization of the same |
| 05/15/2013 | CN101926976B Pill for treating angiitis |
| 05/15/2013 | CN101772494B 4-pyrimidinesulfamide derivative |